Fifth Third Bancorp
CLVS

Fifth Third Bancorp’s Clovis Oncology, Inc. CLVS Stock Holding History

Fifth Third Bancorp’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$4K – 2825
2021
Q3 		$4K Hold
1,000
– – ﹤0.01% 2301
2021
Q2 		$6K Buy
+1,000
New +$5.86K ﹤0.01% 2179
2018
Q3 		– Sell
-89
Closed -$4K – 2358
2018
Q2 		$4K Hold
89
– – ﹤0.01% 2109
2018
Q1 		$5K Hold
89
– – ﹤0.01% 2067
2017
Q4 		$6K Sell
89
-305
-77% -$21.3K ﹤0.01% 1977
2017
Q3 		$32K Buy
394
+182
+86% +$14.4K ﹤0.01% 1451
2017
Q2 		$20K Buy
+212
New +$13K ﹤0.01% 1553
2017
Q1 		– Sell
-642
Closed -$29K – 2249
2016
Q4 		$29K Sell
642
-1,275
-67% -$44.9K ﹤0.01% 1519
2016
Q3 		$69K Buy
+1,917
New +$41.1K ﹤0.01% 1215

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fifth Third Bancorp's CLVS Position: Q4 2021 in Review

Fifth Third Bancorp sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 1,000 shares — an estimated $4K sold.

Fifth Third Bancorp first reported a position in CLVS in Q3 2016 and held it in 9 quarters. The position peaked at $69K in Q3 2016. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Fifth Third Bancorp reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,000 Clovis Oncology, Inc. shares in Q4 2021, an estimated $4K.
  • Fifth Third Bancorp first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 9 quarters.
  • Fifth Third Bancorp's Clovis Oncology, Inc. position peaked at $69K in Q3 2016.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Fifth Third Bancorp's 13F filing for Q4 2021, filed 1 Feb 2022.